Invention Grant
- Patent Title: (S)-enantiomer of mepazine
-
Application No.: US14900527Application Date: 2014-06-25
-
Publication No.: US09718811B2Publication Date: 2017-08-01
- Inventor: Daniel Krappmann , Daniel Nagel , Florian Schlauderer , Katja Lammens , Karl-Peter Hopfner , Robert A. Chrusciel , Dale L. Kling
- Applicant: Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) , Ludwig-Maximilians-Universität München
- Applicant Address: DE DE
- Assignee: Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH),Ludwig-Maximilians—Universität München
- Current Assignee: Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH),Ludwig-Maximilians—Universität München
- Current Assignee Address: DE DE
- Agency: Choate Hall & Stewart LLP
- Agent Brenda Herschbach Jarrell; Robert N. Sahr
- Priority: EP13003260 20130626
- International Application: PCT/EP2014/063446 WO 20140625
- International Announcement: WO2014/207067 WO 20141231
- Main IPC: C07D417/06
- IPC: C07D417/06 ; C07D211/22
Abstract:
The present invention relates to the (S)-enantiomer of mepazine, its applicability in therapy, a pharmacological composition comprising (S)-mepazine, and processes for the preparation of (S)-mepazine and one of its intermediates.
Public/Granted literature
- US20160137635A1 THE (S)-ENANTIOMER OF MEPAZINE Public/Granted day:2016-05-19
Information query
